[Inflammatory osteoarthritis of the hands - challenges in diagnosis and therapy].
Symptomatic osteoarthritis of the hand occurs in 5-20 % of the population ≥ 40 years. The diagnosis is made based on the clinical appearance, e. g. bony enlargements of small finger joints, pain and short morning stiffness. Laboratory or X-ray examinates can however be useful to exclude other rheumatic diseases. Non-pharmacological therapy options include patient education, physio- and occupational therapeutic exercise to strengthen the muscles and mobilisation. Topical non-steroidal anti-inflammatory drugs (NSAID) or capsaicin can be effective for mild to intermediate pain. Systemic therapeutics are paracetamol, NSAID or coxibs. Innovative therapy options are currently under investigation in clinical trials.
Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, CC12 Charité - Universitätsmedizin Berlin.
P
P
Klaus
Klinik mit Schwerpunkt Rheumatologie und Klinische Immunologie, CC12 Charité - Universitätsmedizin Berlin.
J
J
Detert
D000284:Administration, Oral; D000287:Administration, Topical; D000368:Aged; D018712:Analgesics, Non-Narcotic / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D015415:Biomarkers / Q000097:blood; D002211:Capsaicin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D018450:Disease Progression; D006801:Humans; D008875:Middle Aged; D009788:Occupational Therapy; D010003:Osteoarthritis / Q000175:diagnosis* / Q000453:epidemiology / Q000534:rehabilitation*; D026741:Physical Therapy Modalities; D011859:Radiography
D018712:Analgesics, Non-Narcotic; D000893:Anti-Inflammatory Agents; D015415:Biomarkers; D002211:Capsaicin